Robert M Minutello

Summary

Affiliation: Cornell University
Country: USA

Publications

  1. ncbi Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry)
    Robert M Minutello
    Department of Medicine Division of Cardiology at Weill Cornell Medical College, 520 East 70th Street, Staar 446, New York, NY 10021, USA
    Am J Cardiol 93:1229-32. 2004
  2. ncbi Door-to-balloon time in primary percutaneous coronary intervention predicts degree of myocardial necrosis as measured using cardiac biomarkers
    Robert M Minutello
    Department of Medicine, Division of Cardiology, Weill Cornell Medical College, New York, New York 10065, USA
    Tex Heart Inst J 37:161-5. 2010
  3. ncbi Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease
    Robert M Minutello
    New York Presbyterian Hospital, Weill Cornell Campus, New York, New York, USA
    J Interv Cardiol 20:458-65. 2007
  4. ncbi Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (Cypher) stents
    Robert M Minutello
    Weill Cornell Medical College, New York, New York, USA
    Am J Cardiol 97:499-501. 2006
  5. ncbi Impact of race and ethnicity on inhospital outcomes after percutaneous coronary intervention (report from the 2000-2001 New York State Angioplasty Registry)
    Robert M Minutello
    Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
    Am Heart J 151:164-7. 2006
  6. ncbi Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 76:513-24. 2010
  7. ncbi Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice
    Luke K Kim
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, New York, NY 10021, USA
    J Invasive Cardiol 22:94-100. 2010
  8. ncbi Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 77:1020-30. 2011
  9. ncbi Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention
    Dmitriy N Feldman
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
    J Invasive Cardiol 21:258-63. 2009
  10. ncbi Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis
    Ehrin J Armstrong
    Division of Cardiology, University of California, Davis Medical Center, Sacramento, California 95817, USA
    JACC Cardiovasc Interv 5:131-40. 2012

Collaborators

Detail Information

Publications19

  1. ncbi Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry)
    Robert M Minutello
    Department of Medicine Division of Cardiology at Weill Cornell Medical College, 520 East 70th Street, Staar 446, New York, NY 10021, USA
    Am J Cardiol 93:1229-32. 2004
    ..5 and >40 kg/m(2)) were at increased risk of MACEs, including mortality after PCI, whereas patients who were moderately to severely obese (BMIs 30 to 40 kg/m(2)) were at lower risk than healthy weight patients...
  2. ncbi Door-to-balloon time in primary percutaneous coronary intervention predicts degree of myocardial necrosis as measured using cardiac biomarkers
    Robert M Minutello
    Department of Medicine, Division of Cardiology, Weill Cornell Medical College, New York, New York 10065, USA
    Tex Heart Inst J 37:161-5. 2010
    ....
  3. ncbi Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease
    Robert M Minutello
    New York Presbyterian Hospital, Weill Cornell Campus, New York, New York, USA
    J Interv Cardiol 20:458-65. 2007
    ..The purpose of this study was to evaluate the efficacy of sirolimus-eluting stents (SES) in the treatment of saphenous vein graft (SVG) disease...
  4. ncbi Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (Cypher) stents
    Robert M Minutello
    Weill Cornell Medical College, New York, New York, USA
    Am J Cardiol 97:499-501. 2006
    ..In conclusion, the pattern of restenosis observed in our study suggests a higher relative incidence of binary restenosis in the overlapped stented segment in patients who receive 2 overlapping Cypher stents...
  5. ncbi Impact of race and ethnicity on inhospital outcomes after percutaneous coronary intervention (report from the 2000-2001 New York State Angioplasty Registry)
    Robert M Minutello
    Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
    Am Heart J 151:164-7. 2006
    ..Studies regarding the impact of race and ethnicity on outcomes after percutaneous coronary intervention (PCI) in the modern era are limited...
  6. ncbi Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 76:513-24. 2010
    ..This study sought to investigate if the efficacy of bivalirudin monotherapy is similar to heparin plus GP IIb/IIIa inhibition in patients with acute coronary syndromes (ACS) treated with clopidogrel following diagnostic angiography...
  7. ncbi Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice
    Luke K Kim
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, New York, NY 10021, USA
    J Invasive Cardiol 22:94-100. 2010
    ..This study sought to evaluate the short- and long-term efficacy and safety of bivalirudin in diabetic patients undergoing percutaneous coronary intervention (PCI) in contemporary clinical practice...
  8. ncbi Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 77:1020-30. 2011
    ..The aim of this meta-analysis was to assess the prevalence and prognostic value regarding mortality of cTnT or cTnI elevations after nonemergent percutaneous coronary intervention (PCI) in a large number of cohort/registry studies...
  9. ncbi Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention
    Dmitriy N Feldman
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
    J Invasive Cardiol 21:258-63. 2009
    ....
  10. ncbi Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis
    Ehrin J Armstrong
    Division of Cardiology, University of California, Davis Medical Center, Sacramento, California 95817, USA
    JACC Cardiovasc Interv 5:131-40. 2012
    ..The aim of this study was to describe differences in treatment and in-hospital mortality of early, late, and very late stent thrombosis (ST)...
  11. ncbi Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry)
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York, USA
    Am J Cardiol 99:446-9. 2007
    ..In conclusion, as currently practiced in New York State, the strategy of ad hoc PCI in selected patient cohorts appears to be as safe as the strategy of staged procedures...
  12. ncbi Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA
    Am J Cardiol 105:323-32. 2010
    ..927). In conclusion, treatment with a 600-mg loading dose <2 hours before PCI is associated with similar short-term ischemic outcomes and long-term mortality compared to the currently recommended clopidogrel pretreatment regimen...
  13. ncbi Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry)
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York, USA
    Am J Cardiol 98:1334-9. 2006
    ..Elderly patients, in particular octogenarians undergoing emergency PCI, have a substantially higher risk of in-hospital death...
  14. ncbi Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes
    Dmitriy N Feldman
    New York Presbyterian Hospital, Weill Cornell Medical College, New York, USA
    Am J Cardiol 104:1210-5. 2009
    ....
  15. ncbi Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, NY 10021, USA
    Am Heart J 154:695-701. 2007
    ..We investigated whether long-term outcomes after bivalirudin use remained comparable to heparin plus GP IIb/IIIa blockade in current clinical practice of drug-eluting stent use...
  16. ncbi The impact of gender on vessel size in patients with angiographically normal coronary arteries
    Felix Yang
    Department of Medicine, Weill Cornell Medical College, New York, New York 10021, USA
    J Interv Cardiol 19:340-4. 2006
    ..Whether a gender-specific difference in vessel size is contributing to this finding remains controversial. We sought to better define the relationship between gender and coronary artery size...
  17. ncbi Impact of Long-term Statin Therapy on Postprocedural Myocardial Infarction in Patients Undergoing Nonemergency Percutaneous Coronary Intervention
    Jonathan Gordin
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York
    Am J Cardiol 110:1397-404. 2012
    ..In patients with unstable coronary syndromes, long-term statin therapy may be beneficial, particularly at a high dose...
  18. ncbi Safety of single versus multi-vessel angioplasty for patients with acute myocardial infarction and multi-vessel coronary artery disease: report from the New York State Angioplasty Registry
    James A Kong
    New York Presbyterian Hospital-Weill Cornell Campus, New York, New York 10021, USA
    Coron Artery Dis 17:71-5. 2006
    ..Therefore, a strategy of multi-vessel angioplasty during acute myocardial infarction may be safe compared with infarct-related angioplasty in selected patients...
  19. ncbi Can we identify vulnerable patients at risk for ST-segment elevation myocardial infarction based on their clinical characteristics?
    Eric T Chou
    New York Presbyterian Hospital, Weill Cornell Campus, New York, NY 10021, USA
    Coron Artery Dis 15:467-9. 2004
    ..The purpose of this study was to identify clinical predictors of first ST-segment elevation myocardial infarction (STEMI)...